These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Not reported||2008-004931-39||A Study to Determine the Safety, Efficacy, and Pharmacokinetics of 80 mg, 160 mg, and 320 mg ALD518 versus Placebo Administered as Multiple Intravenous Infusions to Patients with Active Rheumatoid Art...||2009-06-17||due-trials|
|Not reported Terminated||2011-002669-40||A Phase 2, Multi-center, Randomized, Double-blind,||2013-02-08||due-trials|
|Listed as ongoing, but also has a completion date and reported results||2016-001306-41||A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients with Chronic Migraine||2018-09-21||bad-data|